EUROPE´S
LEADING
CANNABIS
PLAYER

TICKER: SBX.DE (Xetra)
WKN: A3E5A5
ISIN: DE000A3E5A59

TICKER: SBX.DE (Xetra) / WKN: A3E5A5 / ISIN: DE000A3E5A59

Learn more

About us

SynBiotic Group is Europe's largest, publicly-listed cannabis company, consolidating the strongest player under one roof to make cannabinoids accessible. ​

GERMANY´S
CANNABIS
COMPANY

TICKER: SBX.DE (Xetra)
WKN: A3E5A5
ISIN: DE000A3E5A59

TICKER: SBX.DE (Xetra) / WKN: A3E5A5 / ISIN: DE000A3E5A59

Learn more

We are on a mission to unleash the power of cannabis to improve lives.

We are on a mission to unleash the power of cannabis
to improve lives.

about us

SynBiotic Group is a publicly listed cannabis player

Since 2018, we have been shaping the cannabis world together as SynBiotic SE to unleash the power of the hemp plant. The Buy & Build strategy unites experienced cannabis companies under one roof.

Vertically-integrated Company

SynBiotic Group covers the entire value chain – from cultivation and research & development over production to sales & distribution. We have the clear strategy to further expand along the value chain within our three business areas.  

Category-leading Brands

Since 2018, the SynBiotic Group has been building next-generation brands that are geared towards the needs of tomorrow's customers.

€4bn Market Opportunity

The legalization of recreational cannabis in our home market Germany is near. As a fully-integrated player with decades-long experience, we are ready to capture the massive potential. 

About us

SynBiotic Group is Europe's largest, publicly-listed cannabis company, combining the leading players under one roof to make cannabinoids accessible. ​

Our story

We build next-generation brands addressing the needs of tomorrow’s customers. Our category-leading brands include Hempamed, Princess Stardust, The Hempany, and our full-line medical cannabis brand Hempamed Rx.​

Our approach​

In recent years, the SynBiotic Group has built up a strong presence in all market segments while continuing to expand along the value chain. It is our clear goal to cover the entire value chain - from seed to shelf - and the core of our SynBiotic strategy is reverse vertical integration - from building brands and distribution networks to research and development, production and cultivation.

Brands

SynBiotic Group established leading brands across our areas.​

Top 3 CBD brand
in Germany​

Medical cannabis brand​

CBD Lifestyle brand​

Hemp based beverages like "hemi" (hemp milk)​

Sales & Distribution

SynBiotic Group has built up an extensive sales and distribution infrastructure.​

Successful brand-builder
in the wellness & food CBD market

Wholesaler and retailer of raw materials and end-user products​

Production and distribution of medical and pharmaceutical hemp products​

Import & Distribution of medical cannabis products​

Market access, sales & marketing of products in the field of medical cannabis​

Joint Venture with one of Germany’s largest gastronomy companies to launch first cannabis stores​

R&D & Production

SynBiotic Group operates CBD production & extraction facilities and emerged as one of German's leading hemp processors.​

Plattform for clinical trial with cannabinoids

Company for green processing of hemp (cleaning, peeling, grinding, sieving)

CBD production & extraction company

AI-powered drug discovery platform

Cultivation

SynBiotic Group is optimally positioned with Hanf Farm and their cultivation areas.

Europe´s leading hemp cultivation
(with more than 1000 hectares)

Our areas

While SynBiotic Group has its origins in the Wellness & Food market,
we endeavor to exploit the full potential of the Medical and the Recreational market.

Leveraging our origin​

The European CBD market is exhibiting dynamic growth and is expected to reach nearly €4bn of market value in 2025.​​

The vast majority of European countries allow for the sale of CBD-containing food and wellness products. Especially the German market is set up for success.​​ The broader acceptance of cannabis products, induced by the legalization of recreational cannabis, is expected to significantly boost the cannabis wellness and food area.​

Discover SynBiotic Wellness & Food

Pioneering R&D​ & Innovation​

Growing at nearly 30%, ​the German medical cannabis area is gaining momentum with €0.84bn in market value by 2025.​

In Germany, the dispensing of medical cannabis is closely tied to the existing healthcare system. About half  of the medical cannabis treatments are covered by national health insurance. ​​A legalization and resulting de-stigmatization of cannabis will likely further boost medical use.​​

Discover SynBiotic Medical

Capturing the massive opportunity​​

Germany’s recreational cannabis market is estimated to be €7.4bn, representing an enormous business opportunity upon legalization.​​

Once legalized, Germany's Recreational market is believed one of the largest markets globally. Based on different market estimates, our management assumes a full market potential of €4bn. ​The German government is steering efforts towards the legalization of recreational cannabis by the end of 2023.  

Discover SynBiotic Recreational

Our Team

Led by thought leaders and serial entrepreneurs, SynBiotic Group is pioneering the European cannabis market. Our management experts bring 100+ years of experience along the value chain​.

Daniel Kruse

CEO
SynBiotic

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Bruce Linton

Chairman of the Advisory Board
SynBiotic SE

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Lars Müller

Managing Director
SolidMind Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Rainer Seiler

Managing Director
SynBiotic Sales GmbH

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Dr. Thomas Haffner

Head of R&D
SynBiotic SE

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Johannes Gallois

Managing Director
SynBiotic Distribution GmbH

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Joscha Krauß

Managing Director
MH Medical Hemp GmbH

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Rafael Dulon

Managing Director
Hanf Farm GmbH

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Our Team

Led by thought leaders and serial entrepreneurs, SynBiotic Group is pioneering the European cannabis market. Our management experts bring 200+ years of experience along the value chain​

Lars Müller

Chief executive Officer (CEO)

Alexander Guercueyan

Chief Financial Officer (CFO)

Sebastian Stietzel

Chairman of the supervisory-Board

Thomas Hanke

Supervisory Board

Dr. Marlon Braumann

Supervisory board

Christian Angermayer

Founder apeiron investment group

Michael Auerbach

Founder Subversive Capital

Daniel Kruse

Founder & CEO HEMPRO INTERNATIONAL

Rainer Seiler

Co-Founder SynBiotic sales

Dr. Thomas Haffner

Head of r&D Innovation Synbiotic group

Ralf Klesy

co-founder & CEO Synbiotic sales

Markus Zitzmann-Schreiner

Head of Sales SynBiotic Sales

Dr. Armen Manokian

Chief Scientific Officer of Neuro theryx

Johannes Gallois

Ceo of synbiotic Distribution

Joscha Krause

CEO OF MH MEDICAL HEMP

Rafael Dulon

Founder & CEO HANF FARM GMBH
Discover our Team

Be part of 
our community

For Ventures

SynBiotic supports & invests into companies and teams that fit our group. Please get in touch. 

For Investors

Find out more about our company, news and publications. 


Be part of our community

Become part of Europe’s largest cannabis ecosytem - SynBiotic Group is heavily expanding across our three business areas. We support and invest in companies and teams that fit to our group.